top of page

Publications

Preprints

Selective effects of dopaminergic and noradrenergic degeneration on cognition in Parkinson's disease

Sophie Sun, Victoria Madge, Jelena Djordjevic, Jean-François Gagnon, D. Louis Collins, Alain Dagher, Madeleine Sharp

Online-induced acute stress: sex-dependent improvements in executive function in older adults

Lyla Hawari, Mario Bogdanov, Léah Suissa, A. Ross Otto, and Madeleine Sharp

Dopamine modulates learning-related changes in dynamic striatal-cortical connectivity in Parkinson’s disease

Gerraty RT, Sharp ME, Buch A, Bassett DS, Shohamy D

Publications

Sleep spindle density and temporal clustering are associated with sleep-dependent memory consolidation in Parkinson's disease

Soraya Lahlou, Marta Kaminska, Julien Doyon, Julie Carrier, Madeleine Sharp

Journal of Clinical Sleep Medicine. 2024

Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson’s patients.

Bogdanov M, LoParco S, Otto AR, Sharp M

Neurobiology of Learning and Memory. 2022

Preserved motor memory in Parkinson's disease

Lahlou S, Gabitov E, Owen LLW, Shohamy D, Sharp M

Neuropsychologia. 2022

The impact of pandemic-related worry on cognitive functioning and risk-taking

Kevin da Silva Castanheira, Madeleine Sharp, A. Ross Otto

PLOS ONE 2021

Selective attention is insensitive to reward and to dopamine in Parkinson’s disease

Pilgrim M, Ou ZYA, Sharp M

Scientific Reports 2021

Dopamine is associated with prioritization of reward-associated memories in Parkinson’s disease

Sharp ME, Duncan K, Foerde K, Shohamy D.

Brain. 2020

Dopamine selectively remediates 'model-based' reward learning: a computational approach

Sharp ME, Foerde K, Daw ND, Shohamy D.

Brain. 2016

The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study

Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, Cote L, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Payami H, Molho E, Factor SA, Nutt J, Serrano C, Arroyo M, Pauciulo MW, Nichols WC, Clark LN, Alcalay RN, Marder KS.

Mov Disord. 2015

Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude

Sharp ME, Viswanathan J, McKeown MJ, Appel-Cresswell S, Stoessl AJ, Barton JJ.

Neuropsychologia. 2013

Sensitivity and bias in decision-making under risk: evaluating the perception of reward, its probability and value

Sharp ME, Viswanathan J, Lanyon LJ, Barton JJ.

PLoS One. 2012

Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation

Sharp ME, Marder KS, Côté L, Clark LN, Nichols WC, Vonsattel JP, Alcalay RN.

Mov Disord. 2014

Applause sign in clinically overlapping diseases: a case of TDP-43 proteinopathy

Arkadir D, Greene PE, Waters CH, Moskowitz CB, Sharp ME.

Parkinsonism Relat Disord. 2013

Immunomodulation in adult epilepsy: the role of IVIG

Sharp M, Javidan M.

Can J Neurol Sci. 2012

Delayed restricted diffusion in carbon monoxide leukoencephalopathy

Sharp ME, Chew JB, Heran MK, Pettersen JA.

Can J Neurol Sci. 2012

Online unsupervised performance-based cognitive testing: A feasible and reliable approach to scalable cognitive phenotyping of Parkinson's patients

Nasri Balit, Sophie Sun, Yilin Zhang, Madeleine Sharp

Parkinsonism Relat Disord. 2024

bottom of page